The protective effects of urapidil on lung tissue after intestinal ischemia-reperfusion injury.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      Objective: The effects of urapidil in intestinal ischemia-reperfusion (IR) model were investigated using histopathological and biochemical methods. Materials and methods: Forty Wistar albino rats were subjected to sham operation (Group 1), IR (Group 2), IR+dimethyl sulfoxide (Group 3), IR+urapidil 0.5 mg/kg (Group 4), and IR+urapidil 5 mg/kg (Group 5). Levels of MDA, TAS, TOS, SOD, MPO, NF-κB, caspase-3, and LC3B were measured. Results and discussion: The groups 2 and 3 had significantly higher TOS and MPO levels than the sham group had (p < 0.001), whereas the TAS and SOD levels were significantly lower in Group 2 than in the sham group. In treatment groups, TAS and SOD levels increased, whereas TOS, MPO, and MDA levels decreased compared to Group 2. Caspase-3 and LC3B immunopositivities were seen at severe levels in Group 2 and 3. However, Group 4 and 5 were found to have lower levels of immunopositivity. Immunopositivity was observed in interstitial areas, peribronchial region, and bronchial epithelial cells. A moderate level of NF-κB immunopositivity was seen in Group 2 and 3. Conclusion: Our results show that urapidil is one of the antioxidant agents and protects lung tissue from oxidant effects of intestinal IR injury. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Öz: Amaç İntestinal iskemi-reperfüzyon (IR) modelinde urapidil'in etkileri histopatolojik ve biyokimyasal yöntemler kullanılarak araştırıldı. Gereç ve Yöntem Kırk adet Wistar albino sıçan sham operasyon (Grup 1), IR (Grup 2), IR+dimetil sülfoksit (Grup 3), IR+urapidil 0.5 mg/kg (Grup 4) ve IR+urapidil 5 mg/kg (Grup 5) olarak gruplandı. MDA, TAS, TOS, SOD, MPO, NF-κB, kaspaz-3 ve LC3B seviyeleri ölçüldü. Bulgular ve tartışma Grup 2 ve 3'te sham grubuna göre TOS ve MPO düzeylerinin anlamlı derecede yüksek, (p < 0.001), TAS ve SOD düzeyleri grup 2'de sham grubundan anlamlı derecede düşüktü. Tedavi gruplarında TAS ve SOD seviyeleri yükselirken, TOS, MPO ve MDA düzeyleri Grup 2'ye göre arttı. Kaspaz-3 ve LC3B immünopozitivitesi Grup 2 ve 3'te yoğun seviyelerde görüldü İnterstisyel bölgelerde, peribronşiyal bölgede ve bronşiyal epitel hücrelerinde immünopozitivite gözlendi. Grup 2 ve 3'te orta düzeyde bir NF-kappa B immünopozitivitesi görüldü. Sonuç Sonuçlarımız urapidil'in, antioksidan ajanlardan biri olduğu ve akciğer dokusunu bağırsak IR hasarının oksidan etkilerinden koruduğunu göstermiştir. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Turkish Journal of Biochemistry / Turk Biyokimya Dergisi is the property of De Gruyter and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)